IXIARO Trademark

Trademark Overview

On Monday, December 29, 2008, a trademark application was filed for IXIARO with the United States Patent and Trademark Office. The USPTO has given the IXIARO trademark a serial number of 79065162. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Monday, July 22, 2019. This trademark is owned by Novartis AG. The IXIARO trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
ixiaro

General Information

Serial Number79065162
Word MarkIXIARO
Filing DateMonday, December 29, 2008
Status706 - SECTION 71 ACCEPTED
Status DateMonday, July 22, 2019
Registration Number3658393
Registration DateTuesday, July 21, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 5, 2009

Trademark Statements

Description of MarkThe mark consists of the term "IXIARO" and design. The term "IXIARO" appears in dark green above an abstract design consisting of wavy bands of different lengths that progress from light green to dark green.
Goods and ServicesVaccines for human use
Indication of Colors claimedThe color(s) light green, dark green is/are claimed as a feature of the mark.
Translation of Words in MarkThe wording "IXIARO" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 6, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameValneva Austria GmbH
Party Type32 - New Owner After Registration
Legal Entity Type99 - Other
AddressVienna A-1030
AT
Party NameGlaxosmithkline Biologicals S.A.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressRixensart B1330
BE
Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Saturday, October 15, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 30, 2021LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, December 18, 2020RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Thursday, June 18, 2020NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 22, 2019NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, July 22, 2019REGISTERED-SEC.71 ACCEPTED
Friday, July 12, 2019TEAS SECTION 71 RECEIVED
Thursday, July 4, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, May 24, 2019NEW REPRESENTATIVE AT IB RECEIVED
Thursday, January 31, 2019CHANGE OF OWNER RECEIVED FROM IB
Thursday, January 31, 2019INTERNATIONAL REGISTRATION RENEWED
Saturday, July 21, 2018COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Tuesday, November 3, 2015NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Tuesday, November 3, 2015REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Tuesday, November 3, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 21, 2015TEAS SECTION 71 & 15 RECEIVED
Friday, July 3, 2015CHANGE OF OWNER RECEIVED FROM IB
Sunday, April 28, 2013NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 5, 2010FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, November 3, 2009FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, November 3, 2009FINAL DISPOSITION PROCESSED
Thursday, October 22, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 21, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, May 5, 2009PUBLISHED FOR OPPOSITION
Friday, April 17, 2009REFUSAL PROCESSED BY IB
Wednesday, April 15, 2009NOTICE OF PUBLICATION
Tuesday, March 31, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 27, 2009EXAMINERS AMENDMENT MAILED
Thursday, March 26, 2009ASSIGNED TO LIE
Thursday, March 26, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 26, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, March 26, 2009EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 25, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 25, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 24, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 24, 2009REFUSAL PROCESSED BY MPU
Tuesday, March 24, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 23, 2009NON-FINAL ACTION WRITTEN
Monday, March 23, 2009NON-FINAL ACTION WRITTEN
Wednesday, March 18, 2009ASSIGNED TO EXAMINER
Tuesday, March 10, 2009APPLICATION FILING RECEIPT MAILED
Friday, March 6, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 5, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

ixiaro human vaccines